Internal Medicine, Hematology & Oncology · Providence, RI
NPI
1093731333
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
101 Dudley St
Providence, RI, 02905
Phone (401) 274-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,246 services
Medicare patients, 2024
394
Average age 77
Drug cost, 2024
$4.8M
1,293 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Legare was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 272 times for 162 patients. In total Robert Legare billed 1,246 services in 12 codes, and Medicare paid $85K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 272 | 162 | $12.99 | $3,533 |
| 99215 Office E&M - Established | Facility | 271 | 93 | $113.01 | $31K |
| 99214 Office E&M - Established | Facility | 193 | 145 | $74.07 | $14K |
| 99213 Office E&M - Established | Facility | 98 | 90 | $48.43 | $4,746 |
| 99215 Office E&M - Established | Office | 79 | 45 | $109.69 | $8,666 |
| 99214 Office E&M - Established | Office | 62 | 57 | $65.59 | $4,066 |
| 99232 Hospital E&M - Subsequent | Facility | 54 | 34 | $59.95 | $3,238 |
| 99213 Office E&M - Established | Office | 49 | 47 | $43.44 | $2,128 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 26 | $92.38 | $3,510 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 25 | $12.64 | $468 |
| 99223 Hospital E&M - Initial | Facility | 31 | 29 | $131.82 | $4,086 |
| 99205 Office E&M - New | Facility | 23 | 23 | $137.16 | $3,155 |
| 99442 Telephone Services | Facility | 20 | 17 | $41.53 | $831 |
| 99205 Office E&M - New | Office | 14 | 14 | $114.92 | $1,609 |
By year: 2022 $99K for 1,222 services; 2023 $98K for 963 services; 2024 $85K for 1,246 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert Legare prescribed most often to Medicare patients was Anastrozole, with 250 prescriptions and refills. In total Robert Legare wrote 1,293 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 250 | 618 | 77 | $3,742 |
| Letrozole Generic | 96 | 236 | 28 | $1,838 |
| Xarelto Rivaroxaban | 87 | 97 | 11 | $54K |
| Eliquis Apixaban | 80 | 87 | 15 | $50K |
| Acyclovir Generic | 62 | 105 | 13 | $874 |
| Hydroxyurea Generic | 58 | 126 | 14 | $1,505 |
| Verzenio Abemaciclib | 48 | 48 | Under 11 | $723K |
| Revlimid Lenalidomide | 36 | 36 | Under 11 | $799K |
| Oxycodone Hcl Generic | 33 | 33 | 11 | $425 |
| Gabapentin Generic | 29 | 41 | Under 11 | $277 |
| Ibrance Palbociclib | 27 | 27 | Under 11 | $418K |
| Tamoxifen Citrate Generic | 26 | 71 | Under 11 | $620 |
| Pomalyst Pomalidomide | 25 | 25 | Under 11 | $523K |
| Potassium Chloride Generic | 24 | 27 | Under 11 | $231 |
| Dexamethasone Generic | 23 | 37 | 14 | $533 |
Brand drugs: 455 claims; generic drugs: 838 claims; opioid claims: 43.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert Legare were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.